Fig. 9. a) Corrected fluorescence intensity of the MDCK cells after 3 and 6 hours of treatment with untargeted, (4%) PEG/LUV, and targeted, (0.7%) MD-(4%) PEG/LUV, liposomal formulations. α, β, γ: statistically significant difference between different experimental groups (p < 0.05). LSCM images of the MDCK cells treated with (b and c) Rhodamine labelled untargeted PEGylated liposome, (4%) PEG/LUV, and (d and e) Rhodamine labelled targeted liposome, (0.7%) MD-(4%) PEG/LUV (×40).